Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Telix Pharmaceuticals Limited

Telix Adds Lead-212 Isotope Production Capability
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Investor Webinar: Telix Therapeutics Urology Showcase and Expert Forum
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Recruitment Spotlight: Phase 3 Clinical Trial of Novel Prostate Cancer Radiopharmaceutical Now Active in Miami
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix to Showcase Urology Pipeline at Upcoming ASCO Genitourinary Cancers Symposium (ASCO GU 2025)
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Illuccix® Approved in the United Kingdom
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix Completes Acquisition of RLS (USA) Inc.
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Illuccix® Receives European Approval
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix Presentation to the 43rd Annual J.P. Morgan Healthcare Conference
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix Exceeds FY24 Guidance with US$142M Q4 Revenue
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix to Acquire Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
NOBLE Registry Update: TLX599-CDx PSMA SPECT Imaging of Prostate Cancer Published in EJNMMI Reports
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix Manufacturing Solutions, Brussels South Update: Cyclotron Installation Complete
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix to Add FAP-Targeting Candidates to Theranostic Pipeline
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix ADSs Commence Trading on Nasdaq
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix and Eckert & Ziegler to Partner on Actinium-225 Production Technology
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX TLX
Telix Welcomes CMS Decision to Improve Payments for Diagnostic Radiopharmaceuticals
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX
Telix Partners with Subtle Medical on AI-Enabled SubtlePET™ Software for Faster PET Imaging with Illuccix®
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX
FDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX
Telix Spins Off Rhine Pharma™ to Expand Global Access to Radiopharmaceuticals
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX
Telix Files Form 20-F Registration Statement for Nasdaq ADS
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX
Telix Q3 2024 Business Update – Quarterly Revenue Exceeds AU$200M
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX
First Patient Dosed in Phase II ‘CA-NINE’ Trial of TLX250-CDx for Detection of Recurrent Kidney Cancer After Surgery
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX
Telix to Acquire RLS to Expand North American Manufacturing and Distribution Platform
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX
Telix Announces Cardinal Health as U.S. Commercial Distributor for Zircaix®
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX CAH
‘Highly Accurate’: Telix’s Phase III ZIRCON Trial for Kidney Cancer Imaging Published in The Lancet Oncology
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX
IPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances
From Telix Pharmaceuticals Limited
Via GlobeNewswire
Tickers ASX:TLX
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.